Related Experiment Video
Updated: May 16, 2026

Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion
Published on: November 22, 2024
Polyarteritis nodosa in Croatian children: a retrospective study over the last 20 years
Marija Jelusic1, Masa Vikic-Topic, Danica Batinic
1Division of Paediatric Immunology and Rheumatology, Department of Paediatrics, University Hospital Centre Zagreb, Zagreb University School of Medicine, Kispaticeva 12, 10000, Zagreb, Croatia, marija.jelusic.drazic@gmail.com.
Insights
This study analyzed childhood polyarteritis nodosa (PAN) in Croatia, finding skin and joint issues common. Corticosteroids were primary treatment, with some severe cases needing immunosuppressants.
Area of Science:
- Pediatric Rheumatology
- Vasculitis Research
- Rare Childhood Diseases
Background:
- Polyarteritis nodosa (PAN) is a rare, serious vasculitis affecting children.
- Understanding regional variations in childhood PAN is crucial for diagnosis and management.
Purpose of the Study:
- To characterize the clinical features, treatments, and outcomes of pediatric PAN in Croatia.
- To compare Croatian pediatric PAN cases with international data.
Main Methods:
- A cross-sectional study of 12 children diagnosed with PAN using EULAR/PRES/PRINTO criteria over two decades.
- Data collected on demographics, PAN classification, symptoms, inflammatory markers, autoantibodies, and treatment.
Main Results:
- PAN accounted for 3.8% of childhood vasculitides. Systemic PAN (58%) was most common, followed by microscopic polyangiitis (25%) and cutaneous PAN (17%).
- Key symptoms included skin involvement (90%), arthritis/arthralgia (60%), and central nervous system (CNS) involvement (33%).
- All patients received corticosteroids; immunosuppressants were used for severe cases. Two (17%) microscopic polyangiitis patients died from renal failure.
Conclusions:
- Croatian pediatric PAN exhibits distinct features compared to international cohorts, particularly in symptom prevalence.
- Early diagnosis and tailored treatment, including corticosteroids and immunosuppressants, are vital for managing pediatric PAN and improving outcomes.
Abstract:
To analyze the disease characteristics, treatment modalities and outcome of polyarteritis nodosa (PAN) in Croatian children. Cross-sectional study included all children with PAN diagnosed according to EULAR/PRES/PRINTO criteria during the last two decades. PAN was diagnosed in 12 patients (6 girls and 6 boys) mean age (±SD) 11.33 ± 3.08 years. The share of PAN among all vasculitides was 3.8 %. Systemic PAN was diagnosed in 7 children (58 %), microscopic polyangiitis in 3 (25 %), cutaneous PAN in 2 (17 %). The most consistent symptoms were skin involvement (90 %) and arthritis/arthralgia (60 %). The CNS was affected in 33 % of patients. Inflammatory markers (C-reactive protein and erythrocyte sedimentation rate [ESR]) were elevated in all patients, and anti-neutrophil cytoplasmatic antibodies were positive in all patients with microscopic polyangiitis. Therapy mode for all patients was corticosteroids. Immunosuppressive drugs were used as additional therapy for patients with severe symptoms. Two patients (17 %), both suffering from microscopic polyangiitis, died due to renal failure during the follow-up. In comparison with available studies, we found a difference in distribution of childhood polyarteritis nodosa as well as some clinical characteristics (e.g., higher prevalence of neurological and pulmonary symptoms), while other researched features, laboratory and treatment were similar.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Myocarditis I: Introduction